Pediatrix Medical Group, Inc. (MD) stock
Close on Nov 11, 2026Market cap $2.46BP/E 17.1Yield –
Pediatrix Medical Group, Inc. grew revenue 1.9% to $1.96B over the twelve months to Sep 30, 2026. Operating income rose 6.7% to $212.58M, moving the operating margin from 10.4% to 10.9%. At the latest close the market valued the company at $2.46B, 17.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $2.46B
- P/E ratio
- 17.1
- Price to sales
- 1.25
- Price to book
- 2.89
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.96B
- Net income
- $150.09M
- EPS, diluted
- $1.84
- Book value per share
- $10.66
- Diluted shares
- 80M
Trading
- Next earnings
- Feb 18, 2027 (estimated, before the open)
- Previous close
- $31.62
- Open
- $30.82
- Day's range
- $30.24 – $31.48
- Volume
- 931,886
- Average volume (20 days)
- 752,956
- Index membership
- S&P SmallCap 600 (since Nov 2020), Russell 2000 (since Jun 2020), Russell 3000
- Beta (5 years)
- 0.67
- 52-week range
- $17.23 – $33.74
- RSI (14 days)
- 66.6
- Volatility (1 year)
- 35.1%
- Relative volume
- 1.22×
- WACC
- 7.5%
On 1 of our idea list: Shareholder yield
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MD | S&P 500 | Difference | MD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +18.1% | -2.4% | +20.5 pts | ||
| 3 months | +20.3% | -1.2% | +21.5 pts | ||
| Year to date | +47.0% | +12.3% | +34.7 pts | ||
| 1 year | +39.1% | +12.4% | +26.7 pts | ||
| 3 years | +241.5% | +78.8% | +162.7 pts | +50.6% | +21.4% |
| 5 years | +11.7% | +75.2% | −63.4 pts | +2.2% | +11.9% |
| 10 years | -48.9% | +311.1% | −360.0 pts | -6.5% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Press releases
Releases Pediatrix Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Pediatrix Medical
Services-Hospitals
Pediatrix Medical Group, Inc. delivers specialized physician services focused on newborn, maternal-fetal, and pediatric subspecialty clinical care. Its core clinical offerings include hospital-based neonatal care in neonatal intensive care units, maternal-fetal and obstetrical medical services for complicated pregnancies, pediatric intensive care, inpatient pediatric care, and pediatric surgery. The company additionally operates a newborn hearing screening program, conducts clinical research, and delivers administrative practice support and telehealth solutions. Its primary customers include for-profit and not-for-profit hospital partners, health systems, and referring physicians.
Company profile, executives and historyPediatrix Medical stock: common questions
What is Pediatrix Medical's stock price?
MD closed at $31.45 on Nov 11, 2026, down 0.54% on the day. Over the past 52 weeks it traded between $17.23 and $33.74.
What is Pediatrix Medical's market cap?
Pediatrix Medical was worth $2.46B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MD's P/E ratio?
MD trades at 17.1 times earnings, based on diluted earnings per share of $1.84 over the twelve months to Sep 30, 2026.
How much revenue does Pediatrix Medical make?
Pediatrix Medical reported revenue of $1.96B for the twelve months to Sep 30, 2026, up 1.9% from a year earlier.
Does Pediatrix Medical pay a dividend?
No. Pediatrix Medical has not paid a cash dividend over the last twelve months.
When does Pediatrix Medical report earnings next?
Pediatrix Medical is expected to report Q4 FY2026 results on Feb 18, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has MD stock performed over the past year?
Including dividends, MD returned +39.1% over the past year, against +12.4% for the S&P 500.
How many MD shares are sold short?
4M shares were sold short at the latest FINRA report, 4.61% of the float, or 5.0 days of average trading volume.
Who are Pediatrix Medical's competitors?
Companies most similar to Pediatrix Medical by business, industry and size include SGRY, EHC, PGNY, PRVA, AVAH.
See a number that looks wrong?